Photo by nci from unsplash
To assess the safety and efficacy of a novel immunosuppressive regimen—combination Methotrexate/Prednisone (cMtx/P)—in the management of severe refractory rPPP. Click to show full abstract
To assess the safety and efficacy of a novel immunosuppressive regimen—combination Methotrexate/Prednisone (cMtx/P)—in the management of severe refractory rPPP.
Keywords:
immunosuppressive therapy;
therapy management;
role immunosuppressive;
management refractory;
management;
refractory postprocedural
Journal Title: Journal of Cardiovascular Electrophysiology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Cardiovascular Electrophysiology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!